
By DENISE GRADY
NYT Health
The F.D.A. made the product review a priority, citing shortages that occurred in the wake of several recalls of drugs that were found to contain potentially cancer-causing chemicals.
Published date: March 12, 2019 at 02:00AM
No comments:
Post a Comment